【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Endoscopy Devices 11
3.1.1 Capsule Endoscope Systems 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
4.5 Business Overview 13
4.6 Major Products and Services 14
4.6.1 Overview 14
5 History 15
6 SWOT Analysis 17
6.1 Overview 17
6.2 Given Imaging Ltd. Strengths 18
6.2.1 Focused R&D Activities 18
6.2.2 Broad Product Range 18
6.2.3 Diversified Geographical Presence 18
6.3 Given Imaging Ltd. Weaknesses 19
6.3.1 Dependence on Single Source Suppliers 19
6.4 Given Imaging Ltd. Opportunities 19
6.4.1 Global Endoscopy Devices Market 19
6.4.2 Product Launches and Approvals 19
6.4.3 Growing Aged Population 20
6.4.4 Inorganic Growth Drivers: Acquisitions 20
6.5 Given Imaging Ltd. Threats 21
6.5.1 Rapid Technological Change 21
6.5.2 Healthcare Reform Bill 21
6.5.3 Changing Diagnostic Market Conditions 21
6.5.4 Competitive Landscape 21
7 Competitors 22
8 Competitive Landscape 23
8.1 Endoscopy Devices (Capsule Endoscope Systems), Global, Market Share (%), 2012 23
8.2 Given Imaging Ltd., Endoscopy Devices (Capsule Endoscope Systems), by Region, Market Share (2012) 24
8.3 Given Imaging Ltd., Endoscopy Devices (Capsule Endoscope Systems), by Country, Market Share (2012) 25
9 Key Employees 27
10 Key Employee Biographies 28
11 Company Statement 30
12 Locations And Subsidiaries 32
12.1 Head Office 32
12.2 Other Locations & Subsidiaries 32
13 Financial Deals Landscape 33
13.1 Given Imaging Ltd., Deals Volume Summary, 2007 to 2013 33
14 Given Imaging Ltd. Detailed Deal Summary 35
14.1 Asset Purchase 35
14.1.1 Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For $6 Million 35
14.1.2 Given Imaging Acquires Bravo Monitoring Business From Medtronic 37
14.2 Partnerships 39
14.2.1 Given Imaging Expands Its Distribution Agreement with FUJIFILM 39
14.2.2 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration 40
14.3 Equity Offering 41
14.3.1 Given Imaging Completes Private Placement Of $5.2 Million 41
14.4 Acquisition 42
14.4.1 Given Imaging Completes Acquisition Of Sierra Scientific Instruments From Water Street Healthcare Partners 42
14.4.2 Alpine Biomed Acquires Sierra Scientific Instruments 44
14.4.3 Elron Electronic Acquires Minority Stake In Given Imaging 45
15 Recent Developments 47
15.1 Financial Announcements 47
15.1.1 Feb 12, 2013: Given Imaging Reports Revenue Of $180.5m In 2012 47
15.1.2 Nov 06, 2012: Given Imaging Reports Revenue Of $45.4m In Q3 2012 49
15.1.3 Aug 07, 2012: Given Imaging Reports Revenue Of $44.5m In Q2 2012 50
15.1.4 May 08, 2012: Given Imaging Reports Revenue Of $41.8m In Q1 2012 51
15.1.5 Feb 14, 2012: Given Imaging Reports Revenue Of $178m In 2011 52
15.1.6 Nov 01, 2011: Given Imaging Reports Revenues Of $44.7m In Q3 2011 54
15.1.7 Aug 03, 2011: Given Imaging Reports Revenues Of $44.8m In Q2 2011 55
15.1.8 May 04, 2011: Given Imaging Reports Revenues Of $40m In Q1 2011 56
15.1.9 Feb 15, 2011: Given Imaging Reports Revenues Of $157.8m In 2010 57
15.1.10 Nov 03, 2010: Given Imaging Reports Revenues Of $38.65 Million In Q3 2010 58
15.1.11 Aug 11, 2010: Given Imaging Reports Net Profit Of $2.21 Million In Q2 2010 59
15.1.12 May 11, 2010: Given Imaging Reports Revenues Of $32.1 Million In Q1 2010 60
15.1.13 Feb 16, 2010: Given Imaging Reports Revenues Of $141.8 Million For 2009 61
15.1.14 Nov 04, 2009: Given Imaging Reports Net Profit Of $3.7 Million In Q3 2009 62
15.1.15 Aug 05, 2009: Given Imaging Reports Net Profit Of $4.6 Million In Q2 2009 63
15.1.16 May 06, 2009: Given Imaging Revenues Increases By 12% In Q1 2009 65
15.1.17 Feb 10, 2009: Given Imaging Declares Special Cash Dividend 66
15.1.18 Feb 10, 2009: Given Imaging Reports 2008 Results 66
15.1.19 Jan 19, 2009: Given Imaging To Declare 2008 Results 67
15.1.20 Nov 11, 2008: Given Imaging Reports 3Q 2008 Results 68
15.1.21 Aug 06, 2008: Given Imaging Reports 2Q 2008 Results 69
15.1.22 May 13, 2008: Given Imaging Declares Q1 2008 Results 70
15.1.23 Apr 22, 2008: Given Imaging To Declare Q1 2008 Results 71
15.1.24 Feb 20, 2008: Given Imaging Declares Q4 2007 Results 71
15.1.25 Oct 30, 2007: Given Imaging Reports Q3 2007 Results 72
15.1.26 Aug 01, 2007: Given Imaging Reports Q2 2007 Results 72
15.1.27 May 07, 2007: Given Imaging Declares Q1 2007 Results 73
15.2 Research And Development 73
15.2.1 Oct 25, 2010: Given Imaging Announces New Data Showing PillCam SB To Be Accurate Tool To Evaluate Patients With Crohn’s Disease, Functional GI Disorders And OGIB 73
15.3 Corporate Communications 75
15.3.1 Sep 25, 2008: Given Imaging CFO To Present At The JMP Securities And Maxim Group Growth Confrences 75
15.3.2 Sep 03, 2008: Given Imaging’s CEO To Present At The Morgan Stanley Conference 75
15.4 Legal and Regulatory 75
15.4.1 Jul 09, 2012: Korea Intellectual Property Tribunal Holds Given Imaging Patents Valid 75
15.4.2 Nov 30, 2011: Given Imaging Files Patent Infringement Lawsuit In Korea Against Intromedic 76
15.4.3 Mar 21, 2011: Given Imaging Wins Patent Infringement Lawsuit Against IntroMedic In Germany 76
15.4.4 Jun 17, 2008: Given Imaging Completes Patent Litigation Settlement With Olympus 77
15.5 Product News 77
15.5.1 Jan 03, 2013: Given Imaging Launches ManoView ESO v3.0 Software 77
15.5.2 Nov 27, 2012: Given Imaging Submits PillCam Colon 2 Application To FDA For US Regulatory Clearance 77
15.5.3 Oct 22, 2012: Given Imaging Announces New Studies Highlighting Diverse Applications Of ManoScan At ACG 2012 Annual Meeting 78
15.5.4 Oct 22, 2012: Given Imaging Reports New Studies On PillCam Colon 2 Presented At UEG Week In Amsterdam 79
15.5.5 Oct 21, 2012: Given Imaging Announces Data At UEG Week Confirms PillCam SB’s Role As Diagnostic Gold-Standard For Small Bowel Diseases 80
15.5.6 Sep 19, 2012: Given Imaging Submits PillCam Colon 2 Pivotal Trial Data To Japan’s PMDA For Approval 81
15.5.7 Aug 07, 2012: Given Imaging Expects To Receive FDA And PMDA Approvals For PillCam COLON 2 82
15.5.8 Jul 11, 2012: Given Imaging Announces Reimbursement In Japan For Expanded PillCam SB Indications 82
15.5.9 May 22, 2012: Given Imaging Announces Significant New Data On PillCam SB At DDW 83
15.5.10 May 22, 2012: New Studies Confirm Given Imaging’s PillCam COLON 2’s Feasibility In An Outpatient Setting 84
15.5.11 May 22, 2012: New Studies Confirm Value Of Given Imaging’s PillCam SB In Managing Pediatric Patients With Inflammatory Bowel Disease 85
15.5.12 May 20, 2012: Data Show That Capsule Endoscopy Correlates With Gastroscopy Findings: Given Imaging 85
15.5.13 May 20, 2012: Study Shows That Bravo pH Monitoring Can Be Successfully Extended In Most Cases: Given Imaging 87
15.5.14 Mar 27, 2012: Given Imaging Receives Clearance For Expanded PillCam SB Indications In Japan 88
15.5.15 Mar 12, 2012: Given Imaging Announces Publication Of Colon Capsule Endoscopy Guidelines In Endoscopy 89
15.5.16 Jan 04, 2012: Given Imaging Provides Update On PillCam COLON 2 Pivotal Trial Enrollment 90
15.5.17 Nov 15, 2011: Given Imaging Initiates Pivotal Trial For PillCam COLON 2 In Japan 90
15.5.18 Nov 02, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan AR In Patients With Incontinence 91
15.5.19 Nov 02, 2011: New Studies Confirm Use Of Bravo Wireless pH Monitoring For Assessment Of GERD: Given Imaging 92
15.5.20 Oct 31, 2011: Given Imaging Announces New Studies Validate Use Of PillCam SB To Detect And Monitor Crohn’s Disease 93
15.5.21 Oct 25, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan High Resolution Manometry Testing For Conditions Resulting From Anti-Reflux Surgery 94
15.5.22 Oct 25, 2011: Given Imaging Announces New Studies Showing PillCam SB Can Detect And Monitor Small Bowel Crohn’s Disease 95
15.5.23 Oct 25, 2011: Given Imaging Announces Results From Multiple PillCam COLON Studies Presented At UEGW 2011 96
15.5.24 Oct 18, 2011: Given Imaging Announces New Study Shows Impact Of PillCam SB On Management Of Symptomatic IBD Cases 96
15.5.25 Sep 26, 2011: Given Imaging Announces Positive Data Published In Gastrointestinal Endoscopy Featuring Second-Generation PillCam COLON 97
15.5.26 Jun 06, 2011: Given Imaging Initiates Trial For PillCam COLON 2 Capsule Endoscopy 98
15.5.27 May 23, 2011: Given Imaging Receives FDA Clearance For PillCam ESO 3 99
15.5.28 May 11, 2011: Given Imaging Announces Positive Results From European Multicenter Study Of PillCam COLON 2 99
15.5.29 May 10, 2011: Given Imaging Announces New Clinical Studies Recommend Increased Use Of ManoScan High Resolution Manometry To Diagnose Motility Disorders 101
15.5.30 May 10, 2011: Given Imaging Announces New Presentations Emphasize Value Of PillCam Capsule Endoscopy In Patients With Gastrointestinal Bleeding At Digestive Disease Week 2011 102
15.5.31 May 09, 2011: Given Imaging Announces New Data On Benefits Of Using Bravo Wireless pH Monitoring To Manage GERD 103
15.5.32 May 09, 2011: Given Imaging Announces New Studies Confirm PillCam SB’s Role In Management Of Patients With Suspected And Known Crohn’s Disease 104
15.5.33 Mar 10, 2011: Given Imaging Unveils Updated FDA Clearance For PillCam SB Video Capsule 105
15.5.34 Jan 05, 2011: Given Imaging Initiates Study In US For PillCam COLON 2 Capsule Endoscopy 106
15.5.35 Dec 21, 2010: Given Imaging Receives Reimbursement Code From Brazilian Medical Association For PillCam SB Capsule Endoscopy 106
15.5.36 Apr 29, 2010: Given Imaging Introduces RAPID pH Software And PillCam Express 107
15.5.37 Apr 19, 2010: Given Imaging To Complete RD-300 Trial For PillCam Express Capsule Endoscopy Delivery System In Second Quarter Of 2010 108
15.5.38 Apr 13, 2010: Given Imaging To Complete Phase III Trial For PillCam COLON 2 In First Half Of 2010 108
15.5.39 Apr 12, 2010: Given Imaging To Complete Phase I Trial For PillCam SB2 Capsule In First Quarter Of 2011 108
15.6 Product Approvals 109
15.6.1 Aug 07, 2012: Given Imaging Expects To Receive FDA And PMDA Approvals For PillCam COLON 2 109
15.6.2 Mar 27, 2012: Given Imaging Receives Clearance For Expanded PillCam SB Indications In Japan 109
15.6.3 May 23, 2011: Given Imaging Receives FDA Clearance For PillCam ESO 3 110
15.6.4 Mar 10, 2011: Given Imaging Unveils Updated FDA Clearance For PillCam SB Video Capsule 111
15.6.5 Oct 01, 2009: Given Imaging Receives FDA Nod For PillCam SB Video Capsules And Agile Patency Capsules For Use In Young Children 111
15.6.6 Oct 01, 2009: Given Imaging Receives FDA Nod For PillCam SB Video Capsules And Agile Patency Capsules For Use In Young Children 112
15.6.7 Feb 20, 2008: Given Imaging Announces PillCam COLON Approval In Israel 112
15.7 Clinical Trials 112
15.7.1 Oct 22, 2012: Given Imaging Reports New Studies On PillCam Colon 2 Presented At UEG Week In Amsterdam 112
15.7.2 May 22, 2012: New Studies Confirm Given Imaging’s PillCam COLON 2’s Feasibility In An Outpatient Setting 113
15.7.3 May 22, 2012: Given Imaging Announces Significant New Data On PillCam SB At DDW 114
15.7.4 May 22, 2012: New Studies Confirm Value Of Given Imaging’s PillCam SB In Managing Pediatric Patients With Inflammatory Bowel Disease 115
15.7.5 May 20, 2012: Study Shows That Bravo pH Monitoring Can Be Successfully Extended In Most Cases: Given Imaging 116
15.7.6 May 20, 2012: Data Show That Capsule Endoscopy Correlates With Gastroscopy Findings: Given Imaging 117
15.7.7 Jan 04, 2012: Given Imaging Provides Update On PillCam COLON 2 Pivotal Trial Enrollment 118
15.7.8 Nov 15, 2011: Given Imaging Initiates Pivotal Trial For PillCam COLON 2 In Japan 119
15.7.9 Nov 02, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan AR In Patients With Incontinence 120
15.7.10 Nov 02, 2011: New Studies Confirm Use Of Bravo Wireless pH Monitoring For Assessment Of GERD: Given Imaging 120
15.7.11 Oct 31, 2011: Given Imaging Announces New Studies Validate Use Of PillCam SB To Detect And Monitor Crohn’s Disease 121
15.7.12 Oct 25, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan High Resolution Manometry Testing For Conditions Resulting From Anti-Reflux Surgery 122
15.7.13 Oct 25, 2011: Given Imaging Announces New Studies Showing PillCam SB Can Detect And Monitor Small Bowel Crohn’s Disease 123
15.7.14 Oct 25, 2011: Given Imaging Announces Results From Multiple PillCam COLON Studies Presented At UEGW 2011 124
15.7.15 Oct 18, 2011: Given Imaging Announces New Study Shows Impact Of PillCam SB On Management Of Symptomatic IBD Cases 124
15.7.16 Jun 06, 2011: Given Imaging Initiates Trial For PillCam COLON 2 Capsule Endoscopy 125
15.7.17 May 11, 2011: Given Imaging Announces Positive Results From European Multicenter Study Of PillCam COLON 2 126
15.7.18 May 10, 2011: Given Imaging Announces New Clinical Studies Recommend Increased Use Of ManoScan High Resolution Manometry To Diagnose Motility Disorders 127
15.7.19 May 10, 2011: Given Imaging Announces New Presentations Emphasize Value Of PillCam Capsule Endoscopy In Patients With Gastrointestinal Bleeding At Digestive Disease Week 2011 128
15.7.20 May 09, 2011: Given Imaging Announces New Studies Confirm PillCam SB’s Role In Management Of Patients With Suspected And Known Crohn’s Disease 130
15.7.21 May 09, 2011: Given Imaging Announces New Data On Benefits Of Using Bravo Wireless pH Monitoring To Manage GERD 131
15.7.22 Jan 05, 2011: Given Imaging Initiates Study In US For PillCam COLON 2 Capsule Endoscopy 132
15.7.23 Apr 19, 2010: Given Imaging To Complete RD-300 Trial For PillCam Express Capsule Endoscopy Delivery System In Second Quarter Of 2010 132
15.7.24 Apr 13, 2010: Given Imaging To Complete Phase III Trial For PillCam COLON 2 In First Half Of 2010 132
15.7.25 Apr 12, 2010: Given Imaging To Complete Phase I Trial For PillCam SB2 Capsule In First Quarter Of 2011 133
15.8 Other Significant Developments 133
15.8.1 May 18, 2012: Given Imaging To Present New Studies At Digestive Disease Week 2012 133
15.8.2 May 03, 2011: Given Imaging To Present Product Lines At Digestive Disease Week 2011 133
15.8.3 Jan 20, 2009: Given Imaging Announces Expansion Of Distribution Agreement With FUJIFILM 134
15.8.4 Sep 25, 2008: Given Imaging CFO To Present At The JMP Securities And Maxim Group Growth Confrences 134
15.8.5 Sep 03, 2008: Given Imaging’s CEO To Present At The Morgan Stanley Conference 135
15.8.6 Feb 26, 2008: Given Imaging Wins FSS Contract With VA 135
16 Appendix 136
16.1 Research Methodology 137
16.2 Secondary Research 137
16.3 Primary Research 137
16.4 Models 138
16.5 Forecasts 138
16.6 Expert Panels 138
16.7 GlobalData Consulting 138
16.8 Currency Conversion 139
16.9 Contact Us 140
16.10 Disclaimer 140
【レポート販売概要】
■ タイトル：Given Imaging Ltd.：市場シェア分析■ 英文：Given Imaging Ltd. Market Share Analysis
■ 発行日：2013年3月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160638
■ 調査対象地域：グローバル
- ゲーム機の世界市場：テレビゲーム機、携帯型ゲーム機About Gaming Console Gaming consoles are the most popular devices among the various gaming platforms available in the market. These specialized computers are designed for interactive video gaming and are built with similar components, such as a central processing unit (CPU), graphics processing unit (GPU), and random access memory (RAM). Peripherals such as joysticks, mouse, keypads, and others ar …
- 保護パッケージ（包装資材）の世界市場：フォーム式保護パッケージ、硬質式保護パッケージ、フレキシブル式保護パッケージAbout Packaging Protective packaging involves packaging solutions that provide protection and help in preserving consumer and industrial products, equipment, and machineries from any damaging effects during shipping and storage. Vendors in the market provide innovative protective packaging solutions to various industries such as Automotive, Consumer Electronics, Appliances, Pharmaceutical and Reta …
- 世界のLED照明市場動向（2012-2016）TechNavio's analysts forecast the Global LED Lighting market to grow at a CAGR of 35.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the declining average selling price of LEDs. The Global LED Lighting market has also been witnessing an increasing adoption of LEDs. However, the fluctuating global economy could pose a challenge to the growth of this …
- Atrasentan (Microvascular Complications of Diabetes)：市場予測と分析（～2022）Atrasentan (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the spars …
- 淡水化装置の世界市場分析The global water desalination equipment market value is anticipated to reach USD 25.1 billion by 2025, according to a new report by Grand View Research, Inc. Growing demand for water, increasing water need in industries, and rising population are expected to influence product demand over the forecast period. In the past few years, the industry has witnessed increasing investments in R&D activities …
- 韓国の麻酔装置・呼吸装置市場South Korea Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "South Korea Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain …
- 世界のエレクトロクロミックガラス市場2015The Global Electrochromic Glass Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Electrochromic Glass industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Electrochromic Glass market analysis is provided for the international markets including develop …
- 飼料用微量ミネラルの世界市場：有機微量ミネラル、無機微量ミネラルAbout Trace Minerals for Animal Feed Trace minerals are micronutrients that are used in small quantities in animal feed. Though only small quantities of organic trace minerals are added to animal feed, they play an important role in maintaining animal health. Trace minerals used in animal feed can be organic or inorganic in nature. The bioavailability of organic trace minerals is higher than that …
- リキッドバイオプシーの世界市場予測（～2021）The liquid biopsy market is expected to reach USD 1.66 Billion by 2021 from USD 0.58 Billion in 2016, growing at a CAGR of 23.4% during the forecast period of 2016 to 2021. Technological advancements, increasing number of new cancer cases, availability of funding, growing awareness about liquid biopsy through conferences and government initiatives, and benefits of liquid biopsy over solid tumor bi …
- 世界のグルテンフィード（飼料）市場動向と予測（～2019）This research report provides in-depth market insight into the global gluten feed market that is currently witnessing a steady growth owing to the increasing demand for protein-rich feed. Source: Primary Interviews and MarketsandMarkets Analysis Corn gluten feed is a relatively high-fiber, medium energy, medium-protein product that is essentially fed to ruminants. Its fiber is highly digestible by …
- 飲料パッケージ（包装資材）の世界市場：種類別（ボトル、缶、ポーチ、カートン等）、材料別（ガラス、プラスチック、金属、板紙等）分析Beverage manufacturers have witnessed tremendous growth in the last five years. This has influenced the beverage packaging industry substantially and an upsurge was recorded in this industry simultaneously. New technologies have initiated the emergence of innovative packaging designs, but stringent regulations challenged the beverage packaging manufactures to prioritize environment health. Develop …
- 自動車用フレックス燃料エンジンの世界市場2018-2022About Automotive Flex Fuel Engine A flex fuel engine forms a part of flexible fuel vehicles or flex fuel vehicles (FFVs), which blends gasoline with ethanol (E85) or methanol. Technavio’s analysts forecast the Global Automotive Flex Fuel Engine Market to grow at a CAGR of 5.79% during the period 2017-2022. Covered in this report The report covers the present scenario and the growth prospects of th …
- 保証管理システムの世界市場：保証管理ソフトウェア、クレーム管理、トランザクション管理、保証分析、課金/運営管理、保証追跡The warranty management system market size is estimated to grow from USD 1.7 Billion in 2015 to USD 3.4 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 14.4% from 2015 to 2020. In the milieu of automating all service management processes, ineffective claim processing and valuation of warranties lead to the increasing need for warranty management systems. Most organizations are unaware …
- Tedatioxetine (大うつ病性障害)：医薬品市場予測及び分析（～2023）Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiri …
- 防護服の世界市場：材料種類別（アラミド＆ブレンド、ポリオレフィン＆ブレンド、ポリベンズイミダゾール、綿繊維、積層ポリエステル、その他）、用途別（熱、機械、化学、放射線、その他）、エンドユーザー産業別（石油＆ガス、建設＆製造、医薬品、法執行＆軍事、消防、その他）Global Protective Clothing Market was valued at $8.0 billion in 2018, and is expected to reach $12.9 billion by 2026, supported by a CAGR of 6.2% during the forecast period 2019 to 2026. Innovation in textile industry and launch of new fibers have transformed the familiar functions of conventional textile to the advance textile industry. Protective clothing are manufactured using traditional texti …
